文献速递细菌感染、耐药与抗菌药物

猪链球菌减毒活疫苗可抑制链球菌中毒性休克样综合征并提供序列型非依赖性保护

A Streptococcus suis Live Vaccine Suppresses Streptococcal Toxic Shock-Like Syndrome and Provides Sequence Type-Independent Protection.
PubMed 文献 · J Infect Dis · 2019-01-01

本研究在感染性猪链球菌菌株SC19中删除5个毒力相关基因(sly、scpA、ssnA、fhb、ssads)构建表达荚膜多糖的减毒突变株2015033,并在体外和体内评价其安全性与免疫效果。结果显示突变株生长能力和荚膜多糖生成未受影响、无细胞毒性、更易被天然免疫清除、侵袭能力减弱且对小鼠无致病性;免疫2015033可激发T细胞依赖性免疫、抑制链球菌中毒性休克样综合征并提供序列型非依赖性保护。

要点

  • 删除5个毒力相关基因不影响2015033的生长能力和荚膜多糖生成。
  • 2015033在体外和体内更易被天然免疫清除,对小鼠无致病性。
  • 免疫2015033可抑制链球菌中毒性休克样综合征并提供序列型非依赖性保护。

核心结论

  • 本研究展示了多基因缺失策略用于开发针对侵袭性荚膜病原体的有前景减毒活疫苗的可行性。

研究设计与样本

  • 在感染性猪链球菌菌株SC19中删除5个毒力相关因子(sly、scpA、ssnA、fhb和ssads)构建表达荚膜多糖的减毒突变株2015033。
  • 在体外和体内测定2015033的安全性和免疫效果。

主要发现

  • 删除5个基因未影响2015033的生长能力和荚膜多糖生成,且该突变株在不同细胞模型中未显示细胞毒性。
  • 2015033在体外和体内均更易被天然免疫清除。
  • 2015033在不同小鼠器官(脑、肺和肝)中侵袭能力减弱,对小鼠无致病性且炎症诱导能力弱。
  • 免疫2015033可激发T细胞依赖性免疫、抑制链球菌中毒性休克样综合征,并在感染期间为小鼠提供序列型非依赖性保护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Streptococcus suis is an encapsulated zoonotic pathogen. Increasing antimicrobial resistance invokes the need for effective vaccines. Despite many attempts to develop an effective vaccine, none is currently available. METHODS: A capsular polysaccharide (CPS)-expressing attenuated mutant 2015033 was constructed by deleting 5 virulence-associated factors (sly, scpA, ssnA, fhb, and ssads) in an infective S. suis strain SC19. The safety and immune effect of 2015033 were determined both in vitro and in vivo. RESULTS: Deletion of 5 genes did not impact the growth ability and CPS generation of 2015033, and the mutant exhibited no cytotoxicity in different cell models. 2015033 was more easily eliminated by innate immunity both in vitro and in vivo. In addition, 2015033 showed a diminished invasive ability in different mouse organs (brain, lung, and liver) and avirulent properties in mice associated with weak inflammation-inducing ability. Immunization with 2015033 triggered T cell-dependent immunity, suppressed streptococcal toxic shock-like syndrome, and conferred sequence type-independent protection to mice during infection. CONCLUSIONS: This study presents the feasibility of the strategy of multigene deletion for the development of promising live vaccines against invasive encapsulated pathogens.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Li Z, Chang P, Xu J, et al. A Streptococcus suis Live Vaccine Suppresses Streptococcal Toxic Shock-Like Syndrome and Provides Sequence Type-Independent Protection. J Infect Dis. 2019. PMID: 30165645. doi:10.1093/infdis/jiy512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。